CDH1 and CDH1-related diffuse gastric and lobular breast cancer syndrome: By eliminating E-cadherin-negative precancerous cells before they have an opportunity to progress, novel compounds may provide an alternative approach to the prevention of DGC and LBC in HDGC families.